Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says. Watch here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMaruwa Regulatory News (MAW)

Share Price Information for Maruwa (MAW)

Share Price is delayed by 15 minutes
Get Live Data
69070.00    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 0.00 (0.00%)
Market Cap:
MAW Live PriceLast checked at - London Stock Exchange

Intraday Maruwa Share Chart

Half-year Report

29 Oct 2024 09:02

RNS Number : 0325K
Maruwa Co Ld
29 October 2024
Β 

Β 

Β 

Translation

Β 

Notice: This document is an excerpt translation of the original Japanese document and is only for reference purposes. In the event of any discrepancy between this translated document and the original Japanese document, the latter shall prevail.

Β 

Summary of Consolidated Financial Results

for the Six Months Ended September 30, 2024

(Based on Japanese GAAP)

October 29, 2024

Company name:

MARUWA CO., LTD.

Stock exchange listing:

Tokyo, Nagoya

Stock code:

5344

URL https://www.maruwa-g.com/

Representative:

President

Toshiro Kanbe

Inquiries:

Corporate Officer

Daisuke Yamaguchi

TEL 0561-51-0841

Scheduled date to file Semi-annual Securities Report:

November 13, 2024

Scheduled date to commence dividend payments:

December 2, 2024

Preparation of supplementary material on financial results:

Yes

Holding of financial results meeting:

Yes

(for analysts and institutional investors)

Β 

(Amounts less than one million yen are rounded down)

1. Consolidated financial results for the six months ended September 30, 2024 (from April 1, 2024 to September 30, 2024)

(1) Consolidated operating results (cumulative)

Percentages indicate year-on-year changes

Β 

Net sales

Operating profit

Ordinary profit

Profit attributable to owners of parent

Millions of yen

%

Millions of yen

%

Millions of yen

%

Millions of yen

%

Six months ended September 30, 2024

34,822

24.1

12,789

47.9

11,999

24.8

8,440

24.5

Six months ended September 30, 2023

28,063

(5.4)

8,649

(18.5)

9,616

(21.3)

6,777

(21.2)

Β 

Β 

Earnings per share

Diluted earnings per share

Yen

Yen

Six months ended September 30, 2024

684.12

-

Six months ended September 30, 2023

549.38

-

Β 

(2) Consolidated financial position

Total assets

Net assets

Equity ratio

Millions of yen

Millions of yen

%

As of September 30, 2024

131,278

118,030

89.9

As of March 31, 2024

122,515

109,203

89.1

Β 

Β 

2. Cash dividends

Annual dividends per share

1st quarter-end

2nd quarter-end

3rd quarter-end

Fiscal year-end

Total

Yen

Yen

Yen

Yen

Yen

Year ended March 31, 2024

-

43.00

-

43.00

86.00

Year ending March 31, 2025

-

47.00

Year ending March 31, 2025 (Forecast)

-

47.00

94.00

Β 

3. Forecast of consolidated financial results for the year ending March 31, 2025 (from April 1, 2024 to March 31, 2025)

Percentages indicate year-on-year changes

Β 

Net sales

Operating profit

Ordinary profit

Profit attributable to owners of parent

Earnings per share

Millions of yen

%

Millions of yen

%

Millions of yen

%

Millions of yen

%

Yen

Full year

70,300

14.2

23,000

16.2

-

-

-

-

-

Β 

4. Notes

(1) Significant changes in the scope of consolidation during the six months ended September 30, 2024:

No

Β 

(2) Application of special accounting methods for preparing semi-annual consolidated financial statements:

No

Β 

(3) Changes in accounting policies, changes in accounting estimates, and restatement of prior period financial statements

Changes in accounting policies due to revisions to accounting standards and other regulations:

Yes

Changes in accounting policies due to other reasons:

No

Changes in accounting estimates:

No

Restatement of prior period financial statements:

No

Β 

(4) Number of issued shares (common shares)

Total number of issued shares at the end of the period (including treasury shares)

As of September 30, 2024

12,372,000

Β shares

As of March 31, 2024

12,372,000

Β shares

Number of treasury shares at the end of the period

As of September 30, 2024

32,058

Β shares

As of March 31, 2024

34,125

Β shares

Average number of shares during the period (cumulative from the beginning of the fiscal year)

Six months ended September 30, 2024

12,339,942

Β shares

Six months ended September 30, 2023

12,337,296

Β shares

Β 

Β 

Β 

Semi-annual consolidated financial statements

Consolidated balance sheets

Β 

Β 

(Millions of yen)

Β 

As of March 31, 2024

As of September 30, 2024

Assets

Β 

Β 

Current assets

Β 

Β 

Cash and deposits

55,250

64,882

Notes receivable - trade

360

155

Accounts receivable - trade

13,960

14,318

Electronically recorded monetary claims - operating

1,746

1,384

Merchandise and finished goods

2,248

2,103

Work in process

2,960

3,427

Raw materials and supplies

4,575

4,673

Other

2,516

1,586

Allowance for doubtful accounts

(133)

(103)

Total current assets

83,485

92,428

Non-current assets

Β 

Β 

Property, plant and equipment

Β 

Β 

Buildings and structures, net

15,947

14,787

Machinery, equipment and vehicles, net

12,040

11,544

Land

5,005

5,007

Construction in progress

2,952

4,176

Other, net

786

823

Total property, plant and equipment

36,733

36,338

Intangible assets

Β 

Β 

Other

318

396

Total intangible assets

318

396

Investments and other assets

1,977

2,114

Total non-current assets

39,029

38,849

Total assets

122,515

131,278

Β 

Β 

Β 

Β 

(Millions of yen)

Β 

As of March 31, 2024

As of September 30, 2024

Liabilities

Β 

Β 

Current liabilities

Β 

Β 

Notes and accounts payable - trade

2,957

2,618

Electronically recorded obligations - operating

2,355

892

Current portion of long-term borrowings

400

400

Income taxes payable

2,851

3,696

Provision for bonuses

1,042

1,189

Provision for bonuses for directors (and other officers)

124

6

Other

3,091

3,997

Total current liabilities

12,821

12,800

Non-current liabilities

Β 

Β 

Deferred tax liabilities

127

85

Other

361

361

Total non-current liabilities

489

447

Total liabilities

13,311

13,247

Net assets

Β 

Β 

Shareholders' equity

Β 

Β 

Share capital

8,646

8,646

Capital surplus

12,031

12,103

Retained earnings

87,573

95,483

Treasury shares

(210)

(197)

Total shareholders' equity

108,042

116,036

Accumulated other comprehensive income

Β 

Β 

Valuation difference on available-for-sale securities

171

115

Foreign currency translation adjustment

989

1,878

Total accumulated other comprehensive income

1,161

1,994

Total net assets

109,203

118,030

Total liabilities and net assets

122,515

131,278

Β 

Β 

Β 

Consolidated statements of income (cumulative) and consolidated statements of comprehensive income (cumulative)

Consolidated statements of income (cumulative)

Β 

Β 

(Millions of yen)

Β 

Six months ended

September 30, 2023

Six months ended

September 30, 2024

Net sales

28,063

34,822

Cost of sales

14,054

16,101

Gross profit

14,008

18,720

Selling, general and administrative expenses

5,359

5,930

Operating profit

8,649

12,789

Non-operating income

Β 

Β 

Interest income

82

99

Rental income

58

66

Foreign exchange gains

800

-

Other

67

72

Total non-operating income

1,008

237

Non-operating expenses

Β 

Β 

Foreign exchange losses

-

969

Interest expenses

0

0

Rent expenses on real estate for investments

25

31

Other

14

27

Total non-operating expenses

41

1,028

Ordinary profit

9,616

11,999

Extraordinary income

Β 

Β 

Gain on sale of non-current assets

-

0

Gain on sale of investment securities

12

-

Subsidy income

-

2,576

Total extraordinary income

12

2,576

Extraordinary losses

Β 

Β 

Loss on sale and retirement of non-current assets

134

86

Loss on tax purpose reduction entry of non-current assets

-

2,360

Other

7

-

Total extraordinary losses

141

2,447

Profit before income taxes

9,486

12,128

Income taxes - current

2,646

3,745

Income taxes - deferred

62

(58)

Total income taxes

2,708

3,687

Profit

6,777

8,440

Profit attributable to owners of parent

6,777

8,440

Β 

Β 

Β 

Consolidated statements of comprehensive income (cumulative)

Β 

Β 

(Millions of yen)

Β 

Six months ended

September 30, 2023

Six months ended

September 30, 2024

Profit

6,777

8,440

Other comprehensive income

Β 

Β 

Valuation difference on available-for-sale securities

30

(56)

Foreign currency translation adjustment

629

888

Total other comprehensive income

660

832

Comprehensive income

7,438

9,273

Comprehensive income attributable to

Β 

Β 

Comprehensive income attributable to owners of parent

7,438

9,273

Β 

Β 

Β 

Consolidated statements of cash flows

Β 

Β 

(Millions of yen)

Β 

Six months ended

September 30, 2023

Six months ended

September 30, 2024

Cash flows from operating activities

Β 

Β 

Profit before income taxes

9,486

12,128

Depreciation

1,763

2,158

Increase (decrease) in allowance for doubtful accounts

0

(31)

Loss (gain) on sale of investment securities

(4)

-

Loss (gain) on sale and retirement of non-current assets

134

86

Interest and dividend income

(91)

(103)

Interest expenses

0

0

Subsidy income

-

(2,576)

Loss on tax purpose reduction entry of non-current assets

-

2,360

Decrease (increase) in trade receivables

(2,395)

333

Decrease (increase) in inventories

(1,057)

(334)

Increase (decrease) in trade payables

293

(1,150)

Other, net

903

1,020

Subtotal

9,032

13,892

Interest and dividends received

91

103

Interest paid

(0)

(0)

Income taxes refund (paid)

(2,633)

(2,886)

Net cash provided by (used in) operating activities

6,490

11,109

Cash flows from investing activities

Β 

Β 

Purchase of property, plant and equipment

(6,832)

(3,828)

Proceeds from sale of property, plant and equipment

-

0

Payments for retirement of property, plant and equipment

(67)

(72)

Purchase of intangible assets

(35)

(93)

Purchase of investment securities

(84)

(133)

Proceeds from sale of investment securities

166

-

Subsidies received

-

2,676

Other, net

(10)

5

Net cash provided by (used in) investing activities

(6,863)

(1,446)

Cash flows from financing activities

Β 

Β 

Repayments of long-term borrowings

(133)

-

Purchase of treasury shares

(3)

(0)

Proceeds from sale of treasury shares

17

-

Dividends paid

(493)

(530)

Net cash provided by (used in) financing activities

(612)

(531)

Effect of exchange rate change on cash and cash equivalents

333

511

Net increase (decrease) in cash and cash equivalents

(652)

9,643

Cash and cash equivalents at beginning of period

49,585

55,013

Cash and cash equivalents at end of period

48,933

64,656

Β 

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
IR PPGRAUUPCURB
Date   Source Headline
8th May 20267:56 amRNSFinal Results
3rd Feb 20267:00 amRNS3rd Quarter Results
5th Nov 20257:37 amRNSHalf-year Financial Report
31st Jul 20257:00 amRNSAnnual Financial Report
24th Jul 20257:00 amRNS1st Quarter Results
25th Apr 20258:46 amRNSFinal Results
29th Jan 20258:20 amRNS3rd Quarter Results
29th Oct 20249:02 amRNSHalf-year Report
29th Jul 202410:02 amRNS1st Quarter Results
25th Apr 202410:29 amRNSFinal Results
31st Jan 20248:31 amRNS3rd Quarter Results
26th Oct 20238:46 amRNSHalf-year Report
27th Jul 20238:22 amRNS1st Quarter Results
27th Apr 20239:52 amRNSFinal Results
31st Jan 20237:00 amRNS3rd Quarter Results
27th Oct 202210:40 amRNSHalf-year Report
27th Jul 202210:31 amRNS1st Quarter Results
27th Apr 202210:32 amRNSFinal Results
28th Jan 20227:00 amRNS3rd Quarter Results
27th Oct 20212:08 pmRNSHalf-year Report
27th Jul 20219:24 amRNS1st Quarter Results
27th Apr 202110:15 amRNSFinal Results
28th Jan 20219:37 amRNS3rd Quarter Results
28th Oct 20209:20 amRNSHalf-year Report
27th Jul 202010:27 amRNS1st Quarter Results
28th Apr 20209:54 amRNSFinal Results
30th Jan 20209:00 amRNS3rd Quarter Results
30th Oct 20199:23 amRNSHalf-year Report
30th Jul 201910:59 amRNS1st Quarter Results
26th Apr 201910:37 amRNSFinal Results
31st Jan 201910:40 amRNS3rd Quarter Results
30th Oct 201810:22 amRNSHalf-year Report
26th Jul 201811:05 amRNS1st Quarter Results
27th Apr 20189:32 amRNSFinal Results
30th Jan 20189:39 amRNS3rd Quarter Results
31st Oct 201710:19 amRNSHalf-year Report
25th Jul 201711:16 amRNS1st Quarter Results
8th May 201711:32 amRNSFinal Results FY2016
2nd Feb 201710:11 amRNS3rd Quarter Results
31st Oct 201610:19 amRNSHalf-year Report
28th Jul 201611:59 amRNS1st Quarter Results
29th Apr 20167:28 amRNSFinal Results
4th Feb 201610:16 amRNS3rd Quarter Results
30th Oct 20157:00 amRNSHalf Yearly Report
30th Jul 201511:09 amRNS1st Quarter Results
29th Apr 20158:32 amRNSFinal Results
6th Feb 201510:31 amRNS3rd Quarter Results
30th Oct 20141:08 pmRNSHalf Yearly Report
30th Jul 20142:21 pmRNS1st Quarter Results
14th May 20147:00 amRNSFinal Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.